Literature DB >> 9182253

Heterogeneity of tachykinin receptors in the rabbit lung.

S L Millard1, J W Bloom, H I Yamamura.   

Abstract

The tachykinins, substance P (SP) and neurokinin A (NKA), are agonists for the NK(1) and NK(2) receptors, respectively. Tachykinins have various respiratory effects, including bronchoconstriction. This study characterizes tachykinin binding sites in the rabbit lung. We hypothesize that (2-[(125)I]iodohistidyl(1))Neurokinin A ([(125)I]NKA) interacts with NK1 and NK2 binding sites in the rabbit lung. The K d determined from saturation isotherms was 0.69 times/divided by 1.14 nM (geometric mean times/divided by SEM) and the B max was 4.15 + or - 0.22 femtomole/mg protein (arithmetic mean + or - SEM). Competitive inhibition studies with NKA, SP and various selective tachykinin agonists showed the rank order of potency; [beta-Ala(8)]-Neurokinin A 4-10 = SP >> NKA >> [Sar(9),Met(02)11]-Substance P. [beta-Ala(8)]-Neurokinin A 4-10, a selective NK(2) agonist, and SP inhibition of [(125)I]NKA binding were best described using a two-site model. Competitive inhibition studies using the selective nonpeptide NK(2) antagonist (SR 48968) and the selective nonpeptide NK(1) antagonist (CP 96,345) revealed Ki's of 5.5 nM and 8.1 nM, respectively. Our data therefore suggest that [(125)I]NKA binds to both the NK(1) and NK(2) receptors in the lung.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9182253     DOI: 10.1007/BF02529145

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat.

Authors:  F Petitet; J C Beaujouan; M Saffroy; Y Torrens; J Glowinski
Journal:  Biochem Biophys Res Commun       Date:  1993-02-26       Impact factor: 3.575

2.  A potent and selective agonist for NK-2 tachykinin receptor.

Authors:  P Rovero; V Pestellini; R Patacchini; S Giuliani; P Santicioli; C A Maggi; A Meli; A Giachetti
Journal:  Peptides       Date:  1989 May-Jun       Impact factor: 3.750

3.  Molecular characterization of a functional cDNA for rat substance P receptor.

Authors:  Y Yokota; Y Sasai; K Tanaka; T Fujiwara; K Tsuchida; R Shigemoto; A Kakizuka; H Ohkubo; S Nakanishi
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

Review 4.  Neuropeptides in human airways: function and clinical implications.

Authors:  P J Barnes
Journal:  Am Rev Respir Dis       Date:  1987-12

Review 5.  New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization.

Authors:  D Regoli; G Drapeau; S Dion; R Couture
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

6.  [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors.

Authors:  S H Buck; S L Harbeson; C F Hassmann; S A Shatzer; N Rouissi; F Nantel; P L van Giersbergen
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

7.  Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends.

Authors:  A Graham; B Hopkins; S J Powell; P Danks; I Briggs
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

8.  Identification of both NK1 and NK2 receptors in guinea-pig airways.

Authors:  K T McKee; L Millar; I W Rodger; K M Metters
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

9.  Use of selective agonists and antagonists to characterize tachykinin receptors mediating airway responsiveness in anaesthetized guinea-pigs.

Authors:  L Yuan; E Burcher; B S Nail
Journal:  Pulm Pharmacol       Date:  1994-06

Review 10.  The role of sensory neuropeptides in the pathogenesis of bronchial asthma.

Authors:  G F Joos
Journal:  Clin Exp Allergy       Date:  1989-01       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.